Iovance Biotherapeutics, Inc.
US ˙ NasdaqGM ˙ US4622601007

SecurityIOVA / Iovance Biotherapeutics, Inc.
InstitutionIntellectus Partners, LLC
Latest Disclosed Ownership136,446 shares
Latest Disclosed Value $ 478,924
Intellectus Partners, LLC reports 3.02% increase in ownership of IOVA / Iovance Biotherapeutics, Inc.

On April 10, 2026 - Intellectus Partners, LLC filed a 13F-HR form disclosing ownership of 136,446 shares of Iovance Biotherapeutics, Inc. (US:IOVA) valued at $478,925 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 132,446 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of 3.02% during the quarter. The current value of the position is $517,130 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 136,446 4,000 3.02 479 32.41 0.0978
2026-02-10 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 132,446 1,384 1.06 362 27.11 0.0699
2025-11-12 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 131,062 0 0.00 284 26.22 0.0551
2025-08-05 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 131,062 14,850 12.78 225 -41.71 0.0487
2025-04-11 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 116,212 1,300 1.13 387 -54.59 0.0955
2025-02-07 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 114,912 1,583 1.40 850 -20.11 0.1882
2024-11-06 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 113,329 -600 -0.53 1,064 16.54 0.2720
2024-07-18 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 113,929 -4,000 -3.39 914 -47.74 0.2494
2024-05-03 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 117,929 1,250 1.07 1,748 84.28 0.4596
2024-02-05 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 116,679 -3,600 -2.99 949 73.31 0.2738
2023-10-25 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 120,279 250 0.21 547 -35.27 0.1731
2023-07-31 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 120,029 11,150 10.24 845 27.07 0.2536
2023-05-04 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 108,879 21,229 24.22 665 18.75 0.2100
2023-02-02 2022-12-31 13F Iovance Equity 462260100 87,650 41,673 90.64 560 27.27 0.1950
2022-11-14 2022-09-30 13F Iovance Equity 462260100 45,977 0 0.00 440 -13.39 0.1565
2022-08-12 2022-06-30 13F Iovance Common Stock 462260100 45,977 8,377 22.28 508 -18.85 0.1745
2022-05-16 2022-03-31 13F Iovance Common Stock 462260100 37,600 -2,500 -6.23 626 -18.28 0.1869
2022-02-14 2021-12-31 13F Iovance Common Stock 462260100 40,100 -18,700 -31.80 766 -47.17 0.1953
2021-11-16 2021-09-30 13F Iovance Equity 462260100 58,800 750 1.29 1,450 -3.97 0.3510
2021-08-13 2021-06-30 13F Iovance Equity 462260100 58,050 15,500 36.43 1,510 12.10 0.3405
2021-05-17 2021-03-31 13F Iovance Equity 462260100 42,550 950 2.28 1,347 -30.21 0.3700
2021-02-18 2020-12-31 13F/A-1 Iovance Common Stock 462260100 41,600 6,850 19.71 1,930 68.71 0.5776
2021-02-12 2020-12-31 13F Iovance Common Stock 462260100 872 -33,878 1,930 573,846.2865
2020-11-16 2020-09-30 13F Iovance Common Stock 462260100 34,750 5,015 16.87 1,144 40.20 0.4323
2020-08-14 2020-06-30 13F Iovance Equity 462260100 29,735 17,900 151.25 816 130.51 0.3163
2020-05-14 2020-03-31 13F Iovance Equity 462260100 11,835 3,100 35.49 354 46.28 0.1687
2020-01-24 2019-12-31 13F Iovance Common Stock 462260100 8,735 8,735 242 0.0985
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.